Pauline Wimberger
German Cancer Research Center(DE)Heidelberg University(DE)Helmholtz-Zentrum Dresden-Rossendorf(DE)University Hospital Heidelberg(DE)Klinik für Frauenheilkunde(DE)Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe(DE)National Center for Tumor Diseases(DE)Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie(DE)University Hospital Carl Gustav Carus(DE)Klinik und Poliklinik für Psychotherapie und Psychosomatik(DE)Klinik und Poliklinik für Frauenheilkunde und GeburtshilfeDeutschen Konsortium für Translationale Krebsforschung(DE)Technische Universität Dresden(DE)TU Dresden(DE)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Cells and Metastasis
Most-Cited Works
- → ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma(2020)1,861 cited
- → Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial(2020)1,743 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial(2014)1,598 cited
- → Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study(2018)620 cited
- →